Real-world data on the PI3Kd inhibitor idelalisib in relapsed/refractory CLL patients treated in SwedenAgnes Mattsson, Sandra Sylvan,Tom Mulder,Per Axelsson,Fredrik Ellin,Catharina Lewerin,Bertil Uggla,Anders Osterborg,Lotta HanssonLEUKEMIA & LYMPHOMA(2020)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要